Ally Bridge Group (NY) LLC Quant / Systematic

Location: New York, NY

CIK: 0001822947 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value: $180M (100.0% shares, 0.0% debt)

Holdings (22)

— BLUEPRINT MEDICINES CORP 8.5%

Value $15.27M Shares 160,950 Est. Cost $94.86 Unrealized —

SLNO SOLENO THERAPEUTICS INC 8.0%

Value $14.4M Shares 336,486 Est. Cost $29.77 Unrealized +51.9%

CGON CG ONCOLOGY INC 7.8%

Value $14.06M Shares 320,378 Est. Cost $40.84 Unrealized 0.0%

XENE XENON PHARMACEUTICALS INC 7.4%

Value $13.32M Shares 309,369 Est. Cost $38.92 Unrealized +18.2%

— VERONA PHARMA PLC 6.6%

Value $11.85M Shares 736,738 Est. Cost $16.09 Unrealized —

— MERUS N V 6.4%

Value $11.52M Shares 255,928 Est. Cost $20.59 Unrealized —

PRAX PRAXIS PRECISION MEDICINES I 5.4%

Value $9.732M Shares 159,486 Est. Cost $33.00 Unrealized +35.9%

— MIND MEDICINE MINDMED INC 5.2%

Value $9.414M Shares 1,001,452 Est. Cost $9.40 Unrealized —

— AVADEL PHARMACEUTICALS PLC 5.1%

Value $9.239M Shares 547,036 Est. Cost $15.13 Unrealized —

GERN GERON CORP 5.1%

Value $9.11M Shares 2,760,497 Est. Cost $2.61 Unrealized -14.6%

JSPR JASPER THERAPEUTICS INC 4.7%

Value $8.513M Shares 289,943 Est. Cost $17.76 Unrealized 0.0%

KURA KURA ONCOLOGY INC 4.3%

Value $7.786M Shares 365,044 Est. Cost $19.44 Unrealized 0.0%

INSM INSMED INC 3.8%

Value $6.782M Shares 250,000 Est. Cost $27.99 Unrealized 0.0%

DNTH DIANTHUS THERAPEUTICS INC 3.6%

Value $6.509M Shares 216,968 Est. Cost $21.73 Unrealized 0.0%

OLMA OLEMA PHARMACEUTICALS INC 3.5%

Value $6.328M Shares 559,035 Est. Cost $13.44 Unrealized -4.0%

— LYRA THERAPEUTICS INC 3.5%

Value $6.243M Shares 1,003,741 Est. Cost $6.22 Unrealized —

— LONGBOARD PHARMACEUTICALS IN 3.2%

Value $5.844M Shares 270,559 Est. Cost $21.60 Unrealized —

— RAPT THERAPEUTICS INC 2.1%

Value $3.772M Shares 420,000 Est. Cost $8.98 Unrealized —

— MERSANA THERAPEUTICS INC 2.0%

Value $3.59M Shares 801,437 Est. Cost $4.48 Unrealized —

— MARINUS PHARMACEUTICALS INC 2.0%

Value $3.569M Shares 394,773 Est. Cost $9.04 Unrealized —

— PROMIS NEUROSCIENCES INC 1.1%

Value $2.024M Shares 1,059,582 Est. Cost $1.56 Unrealized —

CNTX CONTEXT THERAPEUTICS INC 0.6%

Value $1.002M Shares 725,951 Est. Cost $0.88 Unrealized +28.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	BLUEPRINT MEDICINES CORP	160,950	$15.27M	8.5%	$94.86	—	COM	09627Y109
SLNO	SOLENO THERAPEUTICS INC	336,486	$14.4M	8.0%	$29.77	+51.9%	COM	834203309
CGON	CG ONCOLOGY INC	320,378	$14.06M	7.8%	$40.84	0.0%	COM	156944100
XENE	XENON PHARMACEUTICALS INC	309,369	$13.32M	7.4%	$38.92	+18.2%	COM	98420N105
—	VERONA PHARMA PLC	736,738	$11.85M	6.6%	$16.09	—	SPONSORED ADS	925050106
—	MERUS N V	255,928	$11.52M	6.4%	$20.59	—	COM	N5749R100
PRAX	PRAXIS PRECISION MEDICINES I	159,486	$9.732M	5.4%	$33.00	+35.9%	COM	74006W207
—	MIND MEDICINE MINDMED INC	1,001,452	$9.414M	5.2%	$9.40	—	COM NEW	60255C885
—	AVADEL PHARMACEUTICALS PLC	547,036	$9.239M	5.1%	$15.13	—	SPONSORED ADR	05337M104
GERN	GERON CORP	2,760,497	$9.11M	5.1%	$2.61	-14.6%	COM	374163103
JSPR	JASPER THERAPEUTICS INC	289,943	$8.513M	4.7%	$17.76	0.0%	COM NEW	471871202
KURA	KURA ONCOLOGY INC	365,044	$7.786M	4.3%	$19.44	0.0%	COM	50127T109
INSM	INSMED INC	250,000	$6.782M	3.8%	$27.99	0.0%	COM PAR $.01	457669307
DNTH	DIANTHUS THERAPEUTICS INC	216,968	$6.509M	3.6%	$21.73	0.0%	COM	252828108
OLMA	OLEMA PHARMACEUTICALS INC	559,035	$6.328M	3.5%	$13.44	-4.0%	COM	68062P106
—	LYRA THERAPEUTICS INC	1,003,741	$6.243M	3.5%	$6.22	—	COM	55234L105
—	LONGBOARD PHARMACEUTICALS IN	270,559	$5.844M	3.2%	$21.60	—	COM	54300N103
—	RAPT THERAPEUTICS INC	420,000	$3.772M	2.1%	$8.98	—	COM	75382E109
—	MERSANA THERAPEUTICS INC	801,437	$3.59M	2.0%	$4.48	—	COM	59045L106
—	MARINUS PHARMACEUTICALS INC	394,773	$3.569M	2.0%	$9.04	—	COM NEW	56854Q200
—	PROMIS NEUROSCIENCES INC	1,059,582	$2.024M	1.1%	$1.56	—	COM NEW	74346M406
CNTX	CONTEXT THERAPEUTICS INC	725,951	$1.002M	0.6%	$0.88	+28.0%	COM	21077P108